366 related articles for article (PubMed ID: 11922554)
1. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications.
Bytzer P; Talley NJ; Hammer J; Young LJ; Jones MP; Horowitz M
Am J Gastroenterol; 2002 Mar; 97(3):604-11. PubMed ID: 11922554
[TBL] [Abstract][Full Text] [Related]
2. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes.
Kim JH; Park HS; Ko SY; Hong SN; Sung IK; Shim CS; Song KH; Kim DL; Kim SK; Oh J
World J Gastroenterol; 2010 Apr; 16(14):1782-7. PubMed ID: 20380013
[TBL] [Abstract][Full Text] [Related]
3. Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers.
Jude EB; Tentolouris N; Appleton I; Anderson S; Boulton AJ
Wound Repair Regen; 2001; 9(5):353-9. PubMed ID: 11896978
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients.
Tai TY; Tseng CH; Sung SM; Huang RF; Chen CZ; Tsai SH
J Formos Med Assoc; 1991 Oct; 90(10):936-40. PubMed ID: 1685173
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
6. Role of HbA1c in management of diabetes mellitus.
Al-Ghamdi AA
Saudi Med J; 2004 Mar; 25(3):342-5. PubMed ID: 15048173
[TBL] [Abstract][Full Text] [Related]
7. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up.
Quan C; Talley NJ; Jones MP; Spies J; Horowitz M
Am J Gastroenterol; 2008 Aug; 103(8):2023-30. PubMed ID: 18796098
[TBL] [Abstract][Full Text] [Related]
8. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.
Valensi P; Giroux C; Seeboth-Ghalayini B; Attali JR
J Diabetes Complications; 1997; 11(1):27-34. PubMed ID: 9025010
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
10. High plasma prorenin in diabetes mellitus and its correlation with some complications.
Franken AA; Derkx FH; Man in't Veld AJ; Hop WC; van Rens GH; Peperkamp E; de Jong PT; Schalekamp MA
J Clin Endocrinol Metab; 1990 Oct; 71(4):1008-15. PubMed ID: 2205621
[TBL] [Abstract][Full Text] [Related]
11. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
[TBL] [Abstract][Full Text] [Related]
12. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
Pradeepa R; Anjana RM; Unnikrishnan R; Ganesan A; Mohan V; Rema M
Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
[TBL] [Abstract][Full Text] [Related]
14. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
15. Status of platelets in complicated and uncomplicated diabetes mellitus.
Malhotra KC; Arya RK; Chugh SN; Singla BB
Angiology; 1982 Jun; 33(6):410-7. PubMed ID: 7091771
[No Abstract] [Full Text] [Related]
16. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
17. Poor glycaemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus.
Abid S; Rizvi A; Jahan F; Rabbani F; Islam N; Khan MH; Masood R; Jafri W
J Pak Med Assoc; 2007 Jul; 57(7):345-9. PubMed ID: 17867256
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
19. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases.
Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T
Ann Rheum Dis; 1996 Dec; 55(12):907-14. PubMed ID: 9014585
[TBL] [Abstract][Full Text] [Related]
20. Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Neurourol Urodyn; 2016 Nov; 35(8):1024-1027. PubMed ID: 26352009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
